All biopharmaceuticals articles
-
ArticleLab 4.0 balance: connected, compliant and ready to integrate
Combining connectivity, compliance and automation, Lab 4.0 connectivity simplifies workflows, reduces manual intervention and supports secure digital transformation in modern pharmaceutical laboratories.
-
ArticleSandoz expands biosimilar pipeline through $322m Henlius deal
Sandoz has entered a collaboration with Shanghai Henlius Biotech to develop and commercialise up to 10 biosimilars in a deal worth up to $322 million, expanding its pipeline with assets referencing established therapies including Erbitux, Repatha and Benlysta.
-
NewsBiopharmaceutical PAT market forecast to reach $4.32bn
Growing demand for real-time process monitoring and more consistent biopharmaceutical manufacturing is expected to drive investment in process analytical technology.
-
NewsBioNTech appoints Guido Oelkers as new Chief Executive Officer
German biotech’s incoming leader set ahead of its goal of having multiple approved products by 2030.
-
NewsR&D and tech innovation boosting biopharmaceutical market to 2030
Advanced technology innovation is driving lower R&D costs and progress of targeted treatments such as cell and gene therapies, the research reports.
-
NewsNew mass spectrometry Chapter could “revolutionise” biopharma quality assurance
Launch of the USP general method chapter signals a breakthrough in pharmaceutical drug impurity control, according to biopharma experts.